Page last updated: 2024-11-13
oxathiol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
oxathiol: reagent which complexes with polonium; used to remove absorbed doses of Po-210 in rats; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 23689126 |
SCHEMBL ID | 3450841 |
MeSH ID | M0052832 |
Synonyms (9)
Synonym |
---|
ethanesulfonic acid, 2-(2,3-dimercaptopropoxy)-, sodium salt |
oxathiol |
2-(2,3-dimercaptopropoxy)ethanesulfonic acid sodium salt |
19872-36-7 |
SCHEMBL3450841 |
AKOS025397224 |
sodium;2-[2,3-bis(sulfanyl)propoxy]ethanesulfonate |
DTXSID90941716 |
sodium 2-[2,3-bis(sulfanyl)propoxy]ethane-1-sulfonate |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.13
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.13) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (12.50%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (87.50%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |